Repeated low doses of doxorubicin induce senescence and functional decline in dyn-EHTs which can be rescued using senomorphics.

21 May 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: New therapeutic approaches for heart failure Heart Failure HFA Premium Access Heart Failure 2022

ESC 365 is supported by

ESC 365 is supported by